ANI Pharmaceuticals Baclofen Oral Suspension

Baclofen is a widely prescribed skeletal muscle relaxant used primarily for the treatment of spasticity resulting from multiple sclerosis and spinal cord injuries. While the compound was originally developed by Ciba-Geigy (now part of Novartis) in Switzerland during the 1960s, it is now manufactured by various generic pharmaceutical firms globally.

In this specific case, the product is an oral suspension formulation marketed and distributed by ANI Pharmaceuticals, Inc. The company specializes in the development, manufacturing, and marketing of high-quality branded and generic prescription pharmaceuticals. Their Baclofen oral suspension is typically produced in high-standard facilities in the United States to meet FDA compliance for concentrated liquid medications.

ANI Pharmaceuticals is a publicly traded American company headquartered in Baudette, Minnesota. It operates as an independent entity, focusing on niche markets and liquid dosage forms. The company has grown significantly through strategic acquisitions of drug portfolios from larger pharmaceutical conglomerates, solidifying its position as a major provider of essential generic treatments in the North American market.